🇺🇸 FDA
Patent

US 11020391

CRMP2 sumoylation inhibitors and uses thereof

granted A61KA61K31/452A61K31/4525

Quick answer

US patent 11020391 (CRMP2 sumoylation inhibitors and uses thereof) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/452, A61K31/4525, A61K31/495, A61K31/496